Pharmaxon
	Developer of neurology and neuro-oncology drugs. The company engages in the discovery and development of drugs for nervous system disorders in which cell mobility is modified. The company\'s activities are currently concentrated on the development of therapies for spinal cord injury, memory disorders and glioblastoma. The company spun out of the Development Biology Institute of Marseille Luminy.
	['', 'neuro-oncology drugs', ' ', 'nervous system disorders', ' ', 'neurological drugs', '']
Maxia Pharmaceuticals
	Provider of non-dermatological applications of a patented library of compounds. The company focuses on small molecule drugs that target major diseases such as cancer and metabolic disorders.
	['', 'molecule drugs', ' ', 'metabolic disorders', ' ', 'cervical cancer', '']
Carmel Pharma
	Developer of a closed system drug transfer device. The company provides clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. Their PhaSeal system is a closed system for handling antibiotics and cytostatic drugs which minimizes the leakage and spread of aerosols into the work environment, allowing more efficient handling near the patient.
	['', 'drug handling', ' drug ', 'handling antibiotics', '']
Vantia
	Developer of small molecule drugs. The company develops drugs for the treatment of nocturia, dysmenorrhoea, respiratory disorders, inflammation, oncological and fibrotic diseases.
	['', 'drug development', ' ', 'nocturia treatment', ' ', 'fibrotic disease treatment', '']
Konova
	Developer of anti-obesity drugs. The company develops drugs that are used for the treatment of obesity.
	['', 'anti obesity drug', ' ', 'slimming drug', ' ', 'medical device', '']
Neuromed Pharmaceuticals
	Provider of small molecule drugs for the Biopharmaceutical industry. The company develops drugs targeting neuronal calcium channels to treat neurological disorders with the initial emphasis on chronic pain anxiety and stroke.
	['therapy ', 'drug developer', ' calcium']
Ancile Pharmaceuticals
	Developer of botanical drugs. The company has a multi-drug portfolio, which includes ANPH 101, an investigational drug with indications for sleep maintenance disorders.
	['', 'botanical drug', ' ', 'chronic disease', ' ', 'prescription botanical drug', '']
Neolab
	Developer of antibiotics and generic medicines. The company specializes in registering generic medicines, with a particular focus on respiratory diseases. It also develops anti-inflammatory agents, antibacterial, and cardiovascular drugs.
	['', 'generic medicine', ' antibiotic ', 'respiratory disease', '']
Intercept Pharmaceuticals
	Developer of small molecule drugs for the treatment of chronic liver and metabolic diseases. The company develops therapeutics to treat orphan and more prevalent liver diseases in bile acid chemistry.
	['', 'molecule drug', ' ', 'chronic liver treatment', ' ', 'metabolic disease treatment', '']
Kinaxo Biotechnologies
	Developer of spectrum-specific kinase inhibitors. The company operates as a service company specializing in chemical proteomics methods to support the development of small molecule drugs. The company spun out of the Max Planck Institute of Biochemistry.
	['', 'kinase inhibitors', 'inhibitors', 'chemical proteomics', ' ', 'molecule drugs', '']
KuDOS Pharmaceuticals
	Developer of oncology drugs. The company develops drugs for combination with chemo- and radiotherapy, based on expertise in DNA repair mechanisms for treatment of cancer.
	['', 'cancer treatment', ' ', 'drug discovery', ' ', 'drug delivery', '']
Aposense
	Developer of diagnostic and therapeutic drugs. The company develops diagnostic and therapeutic drugs to identify and cure cells undergoing apoptosis.
	['', 'molecular imaging', ' apoptosis ', 'therapeutic drugs', '']
Morphosys
	MorphoSys AG and its subsidiaries develops and commercializes antibodies for therapeutic applications. It also develops drugs together with its partners in the pharmaceutical and biotechnology industries.
	['', 'antibody technology', ' ', 'human antibody', ' ', 'therapeutic antibody', '']
KeyNeurotek Pharmaceuticals
	Provider of bio pharmaceutical products. The company provides for development and marketing of small molecule drugs for the treatment of neuronal and autoimmune diseases.
	['', 'bio pharmaceutical product', ' ', 'molecule drug', ' ', 'autoimmune disease', '']
